Literature DB >> 22930247

Common pathophysiological mechanisms involved in luteal phase deficiency and polycystic ovary syndrome. Impact on fertility.

Georgios Boutzios1, Maria Karalaki, Evangelia Zapanti.   

Abstract

Luteal phase deficiency (LPD) is a consequence of the corpus luteum (CL) inability to produce and preserve adequate levels of progesterone. This is clinically manifested by short menstrual cycles and infertility. Abnormal follicular development, defects in neo-angiogenesis or inadequate steroidogenesis in the lutein cells of the CL have been implicated in CL dysfunction and LPD. LPD and polycystic ovary syndrome (PCOS) are independent disorders sharing common pathophysiological profiles. Factors such as hyperinsulinemia, AMH excess, and defects in angiogenesis of CL are at the origin of both LPD and PCOS. In PCOS ovulatory cycles, infertility could result from dysfunctional CL. The aim of this review was to investigate common mechanisms of infertility in CL dysfunction and PCOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930247     DOI: 10.1007/s12020-012-9778-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

Review 1.  Metformin for the treatment of the polycystic ovary syndrome.

Authors:  John E Nestler
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

2.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

3.  Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.

Authors:  Deborah S Wachs; Mickey S Coffler; Pamela J Malcom; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

4.  Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.

Authors:  K J Meenakumari; S Agarwal; A Krishna; L K Pandey
Journal:  Braz J Med Biol Res       Date:  2004-10-26       Impact factor: 2.590

5.  Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.

Authors:  Meghan B Stanek; Sherri M Borman; Theodore A Molskness; Janine M Larson; Richard L Stouffer; Phillip E Patton
Journal:  J Clin Endocrinol Metab       Date:  2007-05-08       Impact factor: 5.958

6.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

7.  High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.

Authors:  M J De Souza; B E Miller; A B Loucks; A A Luciano; L S Pescatello; C G Campbell; B L Lasley
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

8.  Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.

Authors:  Napoleone Ferrara; Gretchen Frantz; Jennifer LeCouter; Lisa Dillard-Telm; Thinh Pham; Aparna Draksharapu; Thomas Giordano; Franklin Peale
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells.

Authors:  J M Weiss; S Polack; K Diedrich; O Ortmann
Journal:  Arch Gynecol Obstet       Date:  2003-06-25       Impact factor: 2.344

Review 10.  Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

Authors:  Laura Pellatt; Suman Rice; Helen D Mason
Journal:  Reproduction       Date:  2010-03-05       Impact factor: 3.906

View more
  12 in total

1.  Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development.

Authors:  Aditi S Ambekar; Dhanashree S Kelkar; Sneha M Pinto; Rakesh Sharma; Indira Hinduja; Kusum Zaveri; Akhilesh Pandey; T S Keshava Prasad; Harsha Gowda; Srabani Mukherjee
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

2.  Prospective evaluation of luteal phase length and natural fertility.

Authors:  Natalie M Crawford; David A Pritchard; Amy H Herring; Anne Z Steiner
Journal:  Fertil Steril       Date:  2017-01-05       Impact factor: 7.329

Review 3.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

4.  Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria.

Authors:  Karen C Schliep; Sunni L Mumford; Ahmad O Hammoud; Joseph B Stanford; Kerri A Kissell; Lindsey A Sjaarda; Neil J Perkins; Katherine A Ahrens; Jean Wactawski-Wende; Pauline Mendola; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-27       Impact factor: 5.958

Review 5.  Progesterone and the luteal phase: a requisite to reproduction.

Authors:  Tolga B Mesen; Steven L Young
Journal:  Obstet Gynecol Clin North Am       Date:  2015-01-05       Impact factor: 2.844

Review 6.  Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.

Authors:  Lingling Salang; Danielle M Teixeira; Ivan Solà; Jen Sothornwit; Wellington P Martins; Magdalena Bofill Rodriguez; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2022-08-24

Review 7.  Non-coding RNA in Ovarian Development and Disease.

Authors:  J Browning Fitzgerald; Jitu George; Lane K Christenson
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

8.  A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility.

Authors:  Huiping Liu; Liuting Zeng; Kailin Yang; Guomin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-18       Impact factor: 2.629

Review 9.  Perturbations in Lineage Specification of Granulosa and Theca Cells May Alter Corpus Luteum Formation and Function.

Authors:  Mohamed A Abedel-Majed; Sarah M Romereim; John S Davis; Andrea S Cupp
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 6.055

10.  Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.

Authors:  Chee Wai Ku; John C Allen; Sze Min Lek; Ming Li Chia; Nguan Soon Tan; Thiam Chye Tan
Journal:  BMC Pregnancy Childbirth       Date:  2018-09-05       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.